E
2018 is shaping up to become another year during which our selected small caps get cashed out by takeover bids. We had only one such takeover in 2017, of Stada Artzneimittel, a German generic drug producer, by a hedge fund pair which still owe us money because the final price paid to German shareholders significantly…